Navigation Links
New vaccine protects more effectively against tuberculosis

Max Planck researchers uncover the mechanism by which the new genetically engineered vaccine functionsThe vaccine has been licensed to the Vakzine Projekt Management who will test it in clinical trials early 2006. The responsible mechanisms for the high efficacy of this vaccine has now been deciphered (Journal of Clinical Investigations, August 18, 2005).

Globally, tuberculosis remains the number one killer in adults. Moreover, multi-drug-resistant tuberculosis strains are on the rise which cannot be treated by first-line drugs. A vaccine against tuberculosis, termed BCG is available which, however, fails to protect against the most frequent form of disease, pulmonary tuberculosis in adults. A more efficient vaccine is urgently needed for control of this global threat.

Recombinant BCG, which express listeriolysin and is deleted for the urease gene, has been created and shown to stimulate far more efficacious protection against tuberculosis than the BCG vaccine currently in use. This new vaccine induces cell death in infected host cells, which leads to stimulation of protection by dendritic cells, the most efficacious antigen-presenting cells. As a result, stronger protection against pulmonary tuberculosis has been achieved in preclinical studies. Importantly, the new vaccine also protects against clinical isolates of the Beijing family. These clinical isolates are frequently multi-drug-resistant and more aggressive and hence have started to conquer the globe. It has been assumed that the Beijing isolates emerged in response to drug treatment and vaccination. The new genetically engineered BCG could provide an efficacious measure against this threat.


'"/>

Source:Max-Planck-Gesellschaft


Page: 1

Related biology news :

1. Research advances quest for HIV-1 vaccine
2. A much-needed shot in the arm for HIV vaccine development
3. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
4. Gene vaccine for Alzheimers disease shows promising results
5. Influenza vaccine uses insect cells to speed development
6. Norovirus, AIDS vaccine and Hepatitis Virus
7. HIV vaccine trial breaks ground for future research
8. Live vaccines more effective against horse herpes virus
9. NIAID begins clinical trial of West Nile virus vaccine
10. Designing vaccines by computer
11. Wake Forest scientists find new combination vaccine effective against plague

Post Your Comments:
(Date:11/25/2009)... may be used to boost resistance to, or slow, the ... Medicine researchers report in a study published .... , Parkinson,s disease is caused by a degenerat... known as the substantia nigra, which is responsib... dopamine in late-stage Parkinson,s causes symptom...
(Date:11/25/2009)... Research Laboratory in the University of Haifa,s ...gious Johnson & Johnson Focused Funding grant for ...age in Parkinson,s disease. The award, which is gr...tion and excellence in science, was announced in 2...t an event at the Hyatt Regency Hotel in New Jerse...
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 1Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 2Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 3Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 4GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 1GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 2GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 3
...sts have demonstrated a new way to assess the pote...--a technique that could also be used to monitor a...isticated, noninvasive medical imaging tools. Scie...en National Laboratory, whose findings are reporte...Medicine,s Journal of Nuclear Medicine, used posit...
...s newest polymer innovation, the first DuPont poly...ognized by the China State Intellectual Property O... Visionary Innovation" at a recent award ceremony....ive the 2005 "New Technologies in Renewable Materi...d Environmental Conference, sponsored by the Socie...
...e sclerosis (MS) can be an unpredictable disease. ...healthy nerve cells and disrupts normal nerve sign...s—including tingling, paralysis, pain, fatigue, an...in combination, sporadically or persistently. Alth...-ups are common in the majority of patients. , MS...
Other Biology News:PET/MRI scans may help unravel mechanisms of prenatal drug damage 2PET/MRI scans may help unravel mechanisms of prenatal drug damage 3PET/MRI scans may help unravel mechanisms of prenatal drug damage 4DuPont's first biologically derived polymer receives global recognition 2Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients 2
(Date:11/25/2009)...NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannoun...alogue: ,, BrazilBioethanolMarketAnalysisandFo...p0165503/Brazil-Bioethanol-Market-Analysis-and-For...nalysisandForecaststo2013 ,, Summary ,, Th...obalbioethanolmarketandtheBrazilbioethanolmarketin...
(Date:11/24/2009)...release is available in German . , Whether ...rds: RFID tags (Radio Frequency Identification) ar...e. They make it possible to label objects or goods...y. The appropriate scanner can read and process th... affixed to goods under production conditions of u...
(Date:11/24/2009)... Ambassador to also Visit Detroit...009 -- , , ,Who: David Appia, French Ambassador fo...f the Invest in France Agency, , , , ,What: Ambas...cuss recent pro-business initiatives adopted by Fr...academic landscape for innovation and development....
(Date:11/24/2009)...SANTACRUZ,Calif.,Nov.24/PRNewswire/--Twomorepresti...on,sleadingonlinejobboardandcareerssiteforlifescie...versityarenowmembersofthejobboard,joining28otherma...ard, www.biocareercenter.com ,isonlyforpost-gradua...iencecareersitesontheInternet,BioCareerCenteristhe...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
... BOSTON, Jan. 15 PAREXEL International Corporatio...tical services organization, announced today it ha...ident and Chief Information Officer (CIO). Ms. Hop...mation technology (IT) initiatives and integrating... global basis. , , Prior to joining PAREXEL, Ms. ...
... ST. LOUIS, Jan. 14 As the latest step in its..., Monsanto Company,(NYSE: MON ) today announced ...increase in the quarterly dividend on its common s...are. The dividend is payable on April 24, 2009 to,...we have often said, when farmers succeed we succee...
... LAVAL, QC, Jan. 14 /PRNewswire-FirstCall/ - BioSy...veloping biotherapeutic thermogels for regenerativ...enrolment next month for the Canadian-European piv...Gel(R). To date, the Company has enrolled more tha...l be permitted to enrol additional subjects until ...
Other Biology Technology:PAREXEL Appoints Josephine Hoppe to Chief Information Officer 2PAREXEL Appoints Josephine Hoppe to Chief Information Officer 3PAREXEL Appoints Josephine Hoppe to Chief Information Officer 4Monsanto Board Approves 10 Percent Dividend Increase 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 3BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 4
...micron range are part of your production or produc...particle size is important to you. You need an ana...ations in your sample every time. The N5 Submicron...ectroscopy (PCS) , which determines particle size ...
MiniMACS Separation Unit from Miltenyi Biotec
...body Binding: High, 400 ng IgG/cm 2 (1cm2 = 100 &.../Ionic , Performance Certified: Well-to-Well, CV =...me: 360 µl , Packaging: 5 plates per sealed ...ene formulation , High antibody binding surface im...
SILVER SEQUENCE Staining Reagents from Promega
Biology Products: